# An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B

> **NCT01730508** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 978 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** Pegylated Interferon Alfa (Peginterferon Alfa)

## Key facts

- **NCT ID:** NCT01730508
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-20
- **Primary completion:** 2017-06-25
- **Final completion:** 2017-06-25
- **Target enrollment:** 978 (ACTUAL)
- **Last updated:** 2017-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01730508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01730508, "An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01730508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*